Millipore Sigma Vibrant Logo

265005 Dexamethasone - CAS 50-02-2 - Calbiochem

Dexamethasone, CAS 50-02-2, is one of the most active and highly stable glucocorticoids. Inhibits the expression of inducible, but not constitutive NOS in vascular endothelial cells (IC50 = 5 nM).

Dexamethasone - CAS 50-02-2 - Calbiochem: MSDS (material safety data sheet) o SDS, certificato d’analisi (CoA) e certificato di qualità (CoQ), dossier, brochure e altri documenti disponibili.

Sinonimi: 9α-Fluoro-16α-methylprednisolone

Primary Target: Phosphorylation of rb protein
View Products on Sigmaaldrich.com
265005
Visualizza prezzi e disponibilità

Panoramica

Replacement Information

Tabella delle specifiche principali

CAS #Empirical Formula
50-02-2C₂₂H₂₉FO₅

Prezzi e disponibilità

Numero di catalogo DisponibilitàConfezionamento Qtà/conf Prezzo Quantità
265005-100MG
Verifica della disponibilità in corso...
—
Disponibilità limitata Disponibilità limitata
A magazzino 
Fuori produzione
Disponibili quantità limitate
La disponibilità deve essere confermata
    Prodotti rimanenti: riceverà un nostro avviso
      Prodotti rimanenti: riceverà un nostro avviso
      Will advise
      Contatti il Servizio Clienti
      Contact Customer Service

      		 Fiala di plastica 100 mg
      Ricerca del prezzo in corso...
      Non è stato possibile trovare il prezzo
      La quantità minima deve essere un multiplo di
      Maximum Quantity is
      Al termine dell'ordine Maggiori informazioni
      Lei ha salvato ()
       
      —
      Richiedi il prezzo
      		 —
      Description
      OverviewMost active and highly stable glucocorticoid. Causes a reduction in cyclin A and Cdk2 activity, and inhibition of G1/S transition in osteoblasts. Inhibits the phosphorylation of retinoblastoma (Rb) protein. Inhibits the expression of inducible but not constitutive nitric oxide synthase in vascular endothelial cells (IC50 = 5 nM). Enhances active cation transport in aortic smooth muscle cells by stimulating the Na+ - K+ pump. Induces apoptosis in human thymocytes.
      Catalogue Number265005
      Brand Family Calbiochem®
      Synonyms9α-Fluoro-16α-methylprednisolone
      References
      ReferencesReil, T.D., et al. 2000. J. Surg. Res. 92, 108.
      Smith, E., et al. 2000. J. Biol. Chem. 275, 1992.
      Petit, P.X., et al. 1995. J. Cell Biol. 130, 157.
      Stern, N., et al. 1994. Am. J. Hypertens. 7, 146.
      Donis, J.A., et al. 1993. Biotechniques 15, 786.
      Ohoka, Y., et al. 1993. Biochem. Biophys. Res. Commun. 197, 916.
      Sarin, A., et al. 1993. J. Exp. Med. 178, 1693.
      Vandewalle, A., et al. 1993. J. Cell Physiol. 156, 383.
      Nieto, M.A., et al. 1992. Clin. Exp. Immunol. 88, 341.
      Walsh, D., and Avashia, J. 1992. Cleveland Clin. J. Med. 59, 505.
      Warters, R.L. 1992. Cancer Res. 52, 883.
      Sperber, K., et al. 1991. J. Allergy Clin. Immunol. 87, 490.
      Radomski, M.W., et al. 1990. Proc. Natl. Acad. Sci. USA 87, 10043.
      Bettger, W.J., et al. 1981. Proc. Natl. Acad. Sci. USA 78, 5588.
      Product Information
      CAS number50-02-2
      ATP CompetitiveN
      FormWhite solid
      Hill FormulaC₂₂H₂₉FO₅
      Chemical formulaC₂₂H₂₉FO₅
      HS Code2937 22 29
      ReversibleN
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      ApplicationDexamethasone, CAS 50-02-2, is one of the most active and highly stable glucocorticoids. Inhibits the expression of inducible, but not constitutive NOS in vascular endothelial cells (IC50 = 5 nM).
      Biological Information
      Primary TargetPhosphorylation of rb protein
      Primary Target IC<sub>50</sub>5 nM Inhibiting the expression of inducible but not constitutive nitric oxide synthase in vascular endothelial cells
      Purity≥99% by TLC
      Physicochemical Information
      Cell permeableN
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      RTECSTU3980000
      Safety Information
      R PhraseR: 36/37/38-43-63

      Irritating to eyes, respiratory system and skin.
      May cause sensitization by skin contact.
      Possible risk of harm to the unborn child.
      S PhraseS: 24-26-36/37

      Avoid contact with skin.
      In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
      Wear suitable protective clothing and gloves.
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Carcinogenic / Teratogenic
      Storage +2°C to +8°C
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 2 months at -20°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Numero di catalogo GTIN
      265005-100MG 04055977198508

      Documentation

      Dexamethasone - CAS 50-02-2 - Calbiochem MSDS

      Titolo

      Scheda di sicurezza (MSDS) 

      Dexamethasone - CAS 50-02-2 - Calbiochem Certificati d'Analisi

      TitoloNumero di lotto
      265005

      Riferimenti bibliografici

      Panoramica delle referenze
      Reil, T.D., et al. 2000. J. Surg. Res. 92, 108.
      Smith, E., et al. 2000. J. Biol. Chem. 275, 1992.
      Petit, P.X., et al. 1995. J. Cell Biol. 130, 157.
      Stern, N., et al. 1994. Am. J. Hypertens. 7, 146.
      Donis, J.A., et al. 1993. Biotechniques 15, 786.
      Ohoka, Y., et al. 1993. Biochem. Biophys. Res. Commun. 197, 916.
      Sarin, A., et al. 1993. J. Exp. Med. 178, 1693.
      Vandewalle, A., et al. 1993. J. Cell Physiol. 156, 383.
      Nieto, M.A., et al. 1992. Clin. Exp. Immunol. 88, 341.
      Walsh, D., and Avashia, J. 1992. Cleveland Clin. J. Med. 59, 505.
      Warters, R.L. 1992. Cancer Res. 52, 883.
      Sperber, K., et al. 1991. J. Allergy Clin. Immunol. 87, 490.
      Radomski, M.W., et al. 1990. Proc. Natl. Acad. Sci. USA 87, 10043.
      Bettger, W.J., et al. 1981. Proc. Natl. Acad. Sci. USA 78, 5588.

      Brochure

      Titolo
      Tools and Tips for Analyzing Apoptosis
      Scheda tecnica

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision21-November-2008 RFH
      Synonyms9α-Fluoro-16α-methylprednisolone
      DescriptionMost active and highly stable glucocorticoid. Inhibits the expression of inducible but not constitutive nitric oxide synthase in vascular endothelial cells (IC50 = 5 nM). Enhances active cation transport in aortic smooth muscle cells by stimulating the Na+-K+ pump. Has anti-inflammatory and antirheumatic properties. Induces apoptosis in human thymocytes. In general, 500-1000 nM of dexamethasone is sufficient to induce apoptosis following a 6 h incubation at 37°C.
      FormWhite solid
      CAS number50-02-2
      RTECSTU3980000
      Chemical formulaC₂₂H₂₉FO₅
      Structure formulaStructure formula
      Purity≥99% by TLC
      SolubilityDMSO (25 mg/ml), chloroform or Ethanol
      Storage +2°C to +8°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 2 months at -20°C.
      Toxicity Carcinogenic / Teratogenic
      Merck USA index14, 2943
      ReferencesReil, T.D., et al. 2000. J. Surg. Res. 92, 108.
      Smith, E., et al. 2000. J. Biol. Chem. 275, 1992.
      Petit, P.X., et al. 1995. J. Cell Biol. 130, 157.
      Stern, N., et al. 1994. Am. J. Hypertens. 7, 146.
      Donis, J.A., et al. 1993. Biotechniques 15, 786.
      Ohoka, Y., et al. 1993. Biochem. Biophys. Res. Commun. 197, 916.
      Sarin, A., et al. 1993. J. Exp. Med. 178, 1693.
      Vandewalle, A., et al. 1993. J. Cell Physiol. 156, 383.
      Nieto, M.A., et al. 1992. Clin. Exp. Immunol. 88, 341.
      Walsh, D., and Avashia, J. 1992. Cleveland Clin. J. Med. 59, 505.
      Warters, R.L. 1992. Cancer Res. 52, 883.
      Sperber, K., et al. 1991. J. Allergy Clin. Immunol. 87, 490.
      Radomski, M.W., et al. 1990. Proc. Natl. Acad. Sci. USA 87, 10043.
      Bettger, W.J., et al. 1981. Proc. Natl. Acad. Sci. USA 78, 5588.